Prevagen Maker Inks Deal To Settle Half-Dozen False Ad Suits

By Mike LaSusa (June 24, 2020, 9:34 PM EDT) -- Consumers who accused a Wisconsin-based biotechnology company of lying about the effects of its Prevagen memory supplement asked a Florida federal court on Wednesday to approve a settlement to resolve the claims in that case and a half-dozen others, encompassing up to 3 million buyers.

The Prevagen buyers asked U.S. District Judge Marcia G. Cooke to greenlight the proposed agreement, which would bar Quincy Bioscience LLC from representing that Prevagen improves memory or limits age-related memory problems, except when the claim isn't misleading or when a disclaimer pointing to the source of the claim is included. It would also give partial refunds...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!